Reference : Le 17-butyrate d'hydrocortisone (Locoid), un trentenaire toujours innovateur.
Scientific journals : Article
Human health sciences : Dermatology
http://hdl.handle.net/2268/6071
Le 17-butyrate d'hydrocortisone (Locoid), un trentenaire toujours innovateur.
French
[en] Hydrocortisone 17-butyrate (Locoid), a thirty-year ongoing innovative drug
Pierard, Gérald mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
2006
Revue Médicale de Liège
61
2
128-30
Yes (verified by ORBi)
0370-629X
Belgium
[en] Dermatologic Agents/chemistry/pharmacology ; Humans ; Hydrocortisone/analogs & derivatives/chemistry/pharmacology ; Molecular Structure
[en] Since half a century, dermocorticoids represent worthy compounds in dermatological therapy. About thirty years ago, hydrocortisone 17-butyrate was introduced on the Belgian market. This compound combines good efficiency and reduced risk of side effects. Its topical formulations have been enriched over time. The original Locoid lipocream and Locoid Crelo presentations confer remarkable qualities to the product. We report a synopsis of clinical and translational studies devoted to this unique dermocorticoid.
http://hdl.handle.net/2268/6071

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
17-BUTYRATE.pdfNo commentaryPublisher postprint431.18 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.